DES

Giannopoulos Drug-Eluting Stent Figure 1

Original Contribution

Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel?

06/01/2022

Stefanos Giannopoulos, MD¹; Eric A. Secemsky, MD²; Peter A. Schneider, MD³; Ehrin J. Armstrong, MD¹

Stefanos Giannopoulos, MD1; Eric A. ...

The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...

The application of 2 distinct...

06/01/2022

Journal of Invasive Cardiology

Original Contribution

One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study)

03/30/2018

Gioel Gabrio Secco, MD, PhD¹; Matteo Tebaldi, MD²; Rosario Parisi, MD³; Andrea Cuculo, MD⁴; Carlo Di Mario, MD, PhD⁵; Pietro Sangiorgio, MD⁶; Alfonso Ielasi, MD⁷; Antonio Centola, MD⁴; Rossella Fattori, MD, PhD³; Matteo Vercellino, MD¹; Giovanni Longo, MD⁵; Gianfranco Pistis, MD¹; Simone Biscaglia, MD²; Antonio Ruggiero, MD⁴; Paolo Nicola Marino, MD⁸; Gianluca Campo, MD²

Gioel Gabrio Secco, MD, PhD1; Matteo...

The aim of our study was to evaluate the safety, feasibility, and cost effectiveness of a 48 mm everolimus-eluting stent (EES) during treatment of very long coronary lesions.

The aim of our study was to...

03/30/2018

Journal of Invasive Cardiology

Original Contribution

Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis

11/15/2016

Wassim Mosleh, MB, BCh, BAO¹; Sumeet Gandhi, MD²; Mohamed Elsiddig, MB, BCh, BAO³; Jon-David Schwalm, MD, MSc²; Michael E. Farkouh, MD, MSc⁴

Wassim Mosleh, MB, BCh, BAO1; Sumeet...

The results of this large meta-analysis suggest that patients with DES (n = 39,213) in comparison with BMS implantation (n = 26,461) for PCI to SVG lesions had lower MACE, all-cause mortality, and TVR rates, without a significant reduction in...

The results of this large...

11/15/2016

Journal of Invasive Cardiology